Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Zealand Pharma A/S (ZEAL)

12.29 0.78 (6.78%)

11-15 16:00

Open:

12.18

Pre. Close:

11.51

High:

12.55

Low:

12.18

Volume:

3,438

Market Cap:

375M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

12.562 - 12.623

12.623 - 12.675

Low:

12.035 - 12.105

12.105 - 12.165

Close:

12.186 - 12.294

12.294 - 12.387

Technical analysis  (as of: 2018-11-15 4:36:37 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 15.53     One year: 16.82

Support:

Support1: 11.51    Support2: 9.58

Resistance:

Resistance1: 13.30    Resistance2: 14.40

Pivot:

12.64

Moving Averages:

MA(5): 12.37     MA(20): 12.69

MA(100): 14.52     MA(250): 14.85

MACD:

MACD(12,26): -0.56     Signal(12,26,9): -0.57

%K %D:

%K(14,3): 20.20     %D(3): 28.58

RSI:

RSI(14): 43.79

52-Week:

High: 18.91  Low: 11.51  Change(%): -15.5

Average Vol(K):

3-Month: 1410  10-Days 634

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ZEAL has closed above bottom band by 38.9%. Bollinger Bands are 2.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-11-15T15:19:08-05:00
Zealand Pharma AS (ZEAL) CEO Britt Meelby Jensen on Q3 2018 Results - Earnings Call Transcript

2018-11-15T09:08:15-05:00
Zealand Pharma reports 9M results

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

30.69

Shares Float (M)

30.69

% Held by Insiders

% Held by Institutions

15.70

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

-1.970

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

8.370

PEG Ratio

Profit Margin

Operating Margin

-464.83

Return on Assets (ttm)

-82.0

Return on Equity (ttm)

-148.8

Qtrly Rev. Growth

51.7

Gross Profit (p.s.)

0.199

Sales Per Share

EBITDA (p.s.)

-0.191

Qtrly Earnings Growth

Operating Cash Flow (M)

-48.48

Levered Free Cash Flow (M)

-25.80

Valuation

P/E

-6.24

P/E Growth Ratio

0.07

P/BV

1.47

P/S

942950208.00

P/CF

-7.78

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.